Cargando…

NCAPG Promotes Pulmonary Artery Smooth Muscle Cell Proliferation as a Promising Therapeutic Target of Idiopathic Pulmonary Hypertension: Bioinformatics Analysis and Experiment Verification

Idiopathic pulmonary arterial hypertension (IPAH) is a disease with complex etiology. Currently, IPAH treatment is limited, and patients’ prognosis is poor. This study aimed to explore new therapeutic targets in IPAH through bioinformatics. Two data sets (GSE113439 and GSE130391) meeting the require...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Bowen, Li, You, Shi, Xiaobo, Liu, Peng, Zhang, Yiman, Tian, Hongyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570379/ https://www.ncbi.nlm.nih.gov/pubmed/36233060 http://dx.doi.org/10.3390/ijms231911762

Ejemplares similares

Smooth Muscle Phenotype in Idiopathic Pulmonary Hypertension: Hyper-Proliferative but not Cancerous
por: Perros, Frédéric, et al.
Publicado: (2019)

Regulation of Smooth Muscle Cell Proliferation by NADPH Oxidases in Pulmonary Hypertension
por: Huetsch, John C., et al.
Publicado: (2019)

Pharmacological Alteration of Cellular Mechanical Properties in Pulmonary Arterial Smooth Muscle Cells of Idiopathic Pulmonary Arterial Hypertension
por: Katsuragi, Shinichi, et al.
Publicado: (2021)

Zinc-mediated activation of CREB pathway in proliferation of pulmonary artery smooth muscle cells in pulmonary hypertension
por: Xiao, Genfa, et al.
Publicado: (2021)

Upregulation of IRF9 Contributes to Pulmonary Artery Smooth Muscle Cell Proliferation During Pulmonary Arterial Hypertension
por: Chen, Yong-Jie, et al.
Publicado: (2021)

Traditional Chinese medicine monomers: Targeting pulmonary artery smooth muscle cells proliferation to treat pulmonary hypertension
por: Yang, Xiuli, et al.
Publicado: (2023)

The Role and Regulation of Pulmonary Artery Smooth Muscle Cells in Pulmonary Hypertension
por: He, Shixin, et al.
Publicado: (2020)

Role of Macrophage Migration Inhibitory Factor in the Proliferation of Smooth Muscle Cell in Pulmonary Hypertension
por: Zhang, Bo, et al.
Publicado: (2012)

MURC deficiency in smooth muscle attenuates pulmonary hypertension
por: Nakanishi, Naohiko, et al.
Publicado: (2016)

Smooth muscle Rac1 contributes to pulmonary hypertension
por: Dilasser, Florian, et al.
Publicado: (2022)

Endogenous Estrogen Attenuates Hypoxia-Induced Pulmonary Hypertension by Inhibiting Pulmonary Arterial Vasoconstriction and Pulmonary Arterial Smooth Muscle Cells Proliferation
por: Xu, Dunquan, et al.
Publicado: (2013)

NOD2 deficiency exacerbates hypoxia-induced pulmonary hypertension and enhances pulmonary vascular smooth muscle cell proliferation
por: Kwon, Min-Young, et al.
Publicado: (2018)

Participation of PLK1 and FOXM1 in the hyperplastic proliferation of pulmonary artery smooth muscle cells in pulmonary arterial hypertension
por: Wilson, Jamie L., et al.
Publicado: (2019)

NCAPG Is a Promising Therapeutic Target Across Different Tumor Types
por: Xiao, Cuicui, et al.
Publicado: (2020)

Krüppel-like Factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension
por: Courboulin, Audrey, et al.
Publicado: (2011)

Cysteine-rich 61 (Cyr61) upregulated in pulmonary arterial hypertension promotes the proliferation of pulmonary artery smooth muscle cells
por: Gao, Lan, et al.
Publicado: (2017)

Pulmonary Artery Smooth Muscle Cell Senescence Promotes the Proliferation of PASMCs by Paracrine IL-6 in Hypoxia-Induced Pulmonary Hypertension
por: Wang, Ai-Ping, et al.
Publicado: (2021)

Akt-Dependent Glycolysis-Driven Lipogenesis Supports Proliferation and Survival of Human Pulmonary Arterial Smooth Muscle Cells in Pulmonary Hypertension
por: Jiang, Lifeng, et al.
Publicado: (2022)

Regulation of Pulmonary Vascular Smooth Muscle Contractility in Pulmonary Arterial Hypertension: Implications for Therapy
por: Lyle, Melissa A., et al.
Publicado: (2017)

Effect of EZH2 on pulmonary artery smooth muscle cell migration in pulmonary hypertension
por: Wang, Ying, et al.
Publicado: (2021)

Glycogen Synthase Kinase 3beta Contributes to Proliferation of Arterial Smooth Muscle Cells in Pulmonary Hypertension
por: Sklepkiewicz, Piotr, et al.
Publicado: (2011)

JMJD1C promotes smooth muscle cell proliferation by activating glycolysis in pulmonary arterial hypertension
por: Zhang, Chen, et al.
Publicado: (2023)

Smooth Muscle Myosin Inhibition: A Novel Therapeutic Approach for Pulmonary Hypertension
por: Ho, David, et al.
Publicado: (2012)

CTLA-4 Expression Is a Promising Biomarker of Idiopathic Pulmonary Arterial Hypertension and Allows Differentiation of the Type of Pulmonary Hypertension
por: Tomaszewski, Michał, et al.
Publicado: (2022)

Identification of NCAPG as an Essential Gene for Neuroblastoma Employing CRISPR-Cas9 Screening Database and Experimental Verification
por: Jia, Yubin, et al.
Publicado: (2023)

Role of smooth muscle cell p53 in pulmonary arterial hypertension
por: Wakasugi, Takayuki, et al.
Publicado: (2019)

DUSP5-mediated inhibition of smooth muscle cell proliferation suppresses pulmonary hypertension and right ventricular hypertrophy
por: Ferguson, Bradley S., et al.
Publicado: (2021)

Blockade of JAK2 protects mice against hypoxia‐induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation
por: Zhang, Lei, et al.
Publicado: (2020)

Extracellular vesicles derived from endothelial cells in hypoxia contribute to pulmonary artery smooth muscle cell proliferation in‐vitro and pulmonary hypertension in mice
por: Chen, Tianji, et al.
Publicado: (2022)

STIM2 contributes to enhanced store-operated Ca(2+) entry in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension
por: Song, Michael Y., et al.
Publicado: (2011)

NCAPG as a novel prognostic biomarker in numerous cancers: a meta-analysis and bioinformatics analysis
por: Lin, Jie, et al.
Publicado: (2023)

Iron Metabolism and Idiopathic Pulmonary Arterial Hypertension: New Insights from Bioinformatic Analysis
por: Zou, Hua-Xi, et al.
Publicado: (2021)

Identification of diagnostic biomarkers for idiopathic pulmonary hypertension with metabolic syndrome by bioinformatics and machine learning
por: Lu, Wenzhang, et al.
Publicado: (2023)

Intracellular iron deficiency in pulmonary arterial smooth muscle cells induces pulmonary arterial hypertension in mice
por: Lakhal-Littleton, Samira, et al.
Publicado: (2019)

Transgelin exacerbates pulmonary artery smooth muscle cell dysfunction in shunt‐related pulmonary arterial hypertension
por: Zhou, Jing‐jing, et al.
Publicado: (2022)

Ligustrazine alleviates pulmonary arterial hypertension in rats by promoting the formation of myocardin transcription complex in the nucleus of pulmonary artery smooth muscle cells
por: Yu, Xichao, et al.
Publicado: (2023)

Pulmonary venous remodeling in COPD-pulmonary hypertension and idiopathic pulmonary arterial hypertension
por: Andersen, Kasper Hasseriis, et al.
Publicado: (2017)

Long non-coding RNA CASC2 suppresses pulmonary artery smooth muscle cell proliferation and phenotypic switch in hypoxia-induced pulmonary hypertension
por: Gong, Junsong, et al.
Publicado: (2019)

The Na(+)/H(+) exchanger contributes to increased smooth muscle proliferation and migration in a rat model of pulmonary arterial hypertension
por: Huetsch, John C., et al.
Publicado: (2016)

Nintedanib ameliorates experimental pulmonary arterial hypertension via inhibition of endothelial mesenchymal transition and smooth muscle cell proliferation
por: Tsutsumi, Takeo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_164k9bj691bjv47n6hf24sa9pt